P
Peter D. Wearden
Researcher at Nemours Foundation
Publications - 103
Citations - 2328
Peter D. Wearden is an academic researcher from Nemours Foundation. The author has contributed to research in topics: Ventricular assist device & Extracorporeal membrane oxygenation. The author has an hindex of 25, co-authored 101 publications receiving 2037 citations. Previous affiliations of Peter D. Wearden include Mississippi State University & University of Pittsburgh.
Papers
More filters
Journal ArticleDOI
Berlin Heart EXCOR Pediatric Ventricular Assist Device for Bridge to Heart Transplantation in US Children
Christopher S. Almond,David L.S. Morales,Eugene H. Blackstone,Mark Turrentine,Michiaki Imamura,M. Patricia Massicotte,Lori C. Jordan,Eric J. Devaney,Chitra Ravishankar,Kirk R. Kanter,William L. Holman,Robert Kroslowitz,Christine Tjossem,Lucy Thuita,Gordon A. Cohen,Holger Buchholz,James D. St. Louis,Khanh Nguyen,Robert A. Niebler,Henry L. Walters,Brian Reemtsen,Peter D. Wearden,Olaf Reinhartz,Kristine J. Guleserian,Max B. Mitchell,Mark S. Bleiweis,Charles E. Canter,Tilman Humpl +27 more
TL;DR: Smaller patient size, renal dysfunction, hepatic dysfunction, and biventricular assist device use were associated with mortality, whereas extracorporeal membrane oxygenation before implantation and congenital heart disease were not.
Journal ArticleDOI
Remote Ischemic Preconditioning Decreases Adhesion and Selectively Modifies Functional Responses of Human Neutrophils
Mikiko Shimizu,Pankaj Saxena,Igor E. Konstantinov,Vera Cherepanov,Michael Cheung,Peter D. Wearden,Hua Zhangdong,Michael Schmidt,Gregory P. Downey,Andrew N. Redington +9 more
TL;DR: This study indicates that repetitive IPC of the forearm results in substantial alterations in neutrophil function, including reduced adhesion, exocytosis, phagocyTosis, and modified cytokine secretion.
Journal ArticleDOI
Perioperative use of dexmedetomidine is associated with decreased incidence of ventricular and supraventricular tachyarrhythmias after congenital cardiac operations.
Constantinos Chrysostomou,Joan Sanchez-de-Toledo,Peter D. Wearden,Edmund H. Jooste,Steven Lichtenstein,Patrick M. Callahan,Tunga Suresh,Elizabeth O'Malley,Dana Shiderly,Jamie Haney,Masahiro Yoshida,Richard A. Orr,Ricardo Munoz,Victor O. Morell +13 more
TL;DR: Perioperative use of dexmedetomidine is associated with a significantly decreased incidence of ventricular and supraventricular tachyarrhythmias, without significant adverse effects.
Journal ArticleDOI
Short- and intermediate-term survival after extracorporeal membrane oxygenation in children with cardiac disease.
Constantinos Chrysostomou,Victor O. Morell,Bradley A. Kuch,Elizabeth O’Malley,Ricardo Munoz,Peter D. Wearden +5 more
TL;DR: ECMO was successfully used in children with cardiac disease with 73% and 66% short- and intermediate-term survival, respectively and the majority of the survivors had normal function or only a minimal neurodevelopmental deficit.
Journal ArticleDOI
Activated partial thromboplastin time is a better trending tool in pediatric extracorporeal membrane oxygenation.
Timothy M. Maul,Erin L. Wolff,Bradley A. Kuch,Adam Rosendorff,Victor O. Morell,Peter D. Wearden +5 more
TL;DR: The activated clotting time is not an accurate monitoring tool for heparin management in pediatricextracorporeal membrane oxygenation and cannot be substituted for the clinical laboratory activated partial thromboplastin time values.